Chrissie Walker
About Chrissie Walker
Chrissie Walker serves as the Operations Director at Neuronostics Ltd, where she has worked since 2019. With a background in publishing and project management, she has contributed significantly to the development of operations for a spin-out company from the University of Exeter and has expertise in applying mathematical models and AI in neurological diagnostics.
Current Role at Neuronostics
Chrissie Walker serves as the Operations Director at Neuronostics Ltd, a position she has held since 2019. In this role, she oversees the operational aspects of the company, contributing to its strategic direction and efficiency. Under her leadership, Neuronostics has been recognized as the best South-West startup by Medlink in 2019.
Previous Experience in Publishing and Education
Chrissie Walker has extensive experience in the publishing and education sectors. She worked at IOP Publishing as Executive Publisher in Education from 2012 to 2013. Prior to that, she held various roles including Publications Manager at Dartington Hall Trust from 2007 to 2012 and Publishing Editor at The Royal Society from 2003 to 2007. Additionally, she served as Editorial Controller at Nature Publishing Group from 2001 to 2002.
Research Project Management Background
From 2015 to 2020, Chrissie Walker was employed as a Research Project Manager at the University of Exeter. In this role, she managed research projects and contributed to the development of operations for a spin-out company from the university. Her experience in this position enhanced her expertise in project management within academic settings.
Educational Qualifications
Chrissie Walker studied at the University of Warwick, where she earned a Bachelor of Science (BSc) in Chemistry with Medicinal Chemistry from 1997 to 2000. She also attended Budehaven Community College, which provided her foundational education prior to her university studies.
Expertise in Neurological Conditions
Chrissie Walker has developed expertise in utilizing mathematical models and artificial intelligence to improve diagnosis and prognosis in neurological conditions. This specialization is integral to her work at Neuronostics, where she applies her knowledge to advance the company's mission in the healthcare sector.